Given the effective increase in the expression of BDNF, ERK1/2 and CREB in the treatment group in the alcoholic cognitive impairment mouse model, HME is expected to improve cognitive function and depression through neuronal recovery and regeneration. The gene discussed is CREB1; the disease is major depressive disorder.